Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

EGFL7 Antikörper (AA 24-273)

EGFL7 Reaktivität: Human WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
Produktnummer ABIN1867705
  • Target Alle EGFL7 Antikörper anzeigen
    EGFL7 (EGF-Like-Domain, Multiple 7 (EGFL7))
    Bindungsspezifität
    • 14
    • 5
    • 5
    • 3
    • 3
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 24-273
    Reaktivität
    • 45
    • 20
    • 15
    Human
    Wirt
    • 40
    • 7
    • 1
    • 1
    • 1
    Kaninchen
    Klonalität
    • 44
    • 6
    Polyklonal
    Konjugat
    • 28
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser EGFL7 Antikörper ist unkonjugiert
    Applikation
    • 24
    • 16
    • 11
    • 11
    • 11
    • 9
    • 8
    • 3
    • 3
    • 2
    Western Blotting (WB), Immunohistochemistry (IHC), Immunoprecipitation (IP), Immunocytochemistry (ICC)
    Verwendungszweck
    Polyclonal Antibody to EGF Like Domain Protein, Multiple 7 (EGFL7)
    Spezifität
    The antibody is a rabbit polyclonal antibody raised against EGFL7. It has been selected for its ability to recognize EGFL7 in immunohistochemical staining and western blotting.
    Kreuzreaktivität
    Maus, Schwein
    Aufreinigung
    Antigen-specific affinity chromatography followed by Protein A affinity chromatography
    Immunogen
    RPL643Hu01Recombinant EGF Like Domain Protein, Multiple 7 (EGFL7)
    Isotyp
    IgG
    Top Product
    Discover our top product EGFL7 Primärantikörper
  • Applikationshinweise
    Western blottin:g: 0.5-5 μg/mL,Immunohistochemistry: 5-50 μg/mL,Immunocytochemistry: 5-50 μg/mL,Optimal working dilutions must be determined by end user.
    Kommentare

    The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Konzentration
    0.5 mg/mL
    Buffer
    PBS, pH 7.4, containing 0.02 % Sodium azide, 50 % glycerol.
    Konservierungsmittel
    ProClin, Sodium azide
    Vorsichtsmaßnahmen
    WARNING: Reagents contain sodium azide. Sodium azide is very toxic if ingested or inhaled. Avoid contact with skin, eyes, or clothing. Wear eye or face protection when handling. If skin or eye contact occurs, wash with copious amounts of water. If ingested or inhaled, contact a physician immediately. Sodium azide yields toxic hydrazoic acid under acidic conditions. Dilute azide-containing compounds in running water before discarding to avoid accumulation of potentially explosive deposits in lead or copper plumbing.
    Handhabung
    Avoid repeated freeze-thaw cycles.
    Lagerung
    4 °C,-20 °C
    Informationen zur Lagerung
    Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.
    Haltbarkeit
    12 months
  • Target
    EGFL7 (EGF-Like-Domain, Multiple 7 (EGFL7))
    Andere Bezeichnung
    EGFL7 (EGFL7 Produkte)
    Hintergrund
    ZNEU1, MEGF7, Zneu1, Vascular endothelial statin, EGF Like Domain Containing 7, Epidermal growth factor-like protein 7, Multiple epidermal growth factor-like domains protein 7
Sie sind hier:
Chat with us!